EX-10.1 2 dex101.htm LICENSE AND SUPPLY AGREEMENT CONFIDENTIAL TREATMENT REQUESTED WITH RESPECT TO CERTAIN PORTIONS HEREOF DENOTED WITH “***” LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionThis License and Supply Agreement (the “Agreement”) is made as of October 4, 2010 (the “Effective Date”) by and between Arius Pharmaceuticals, Inc. (“BDSI”), a Delaware corporation and wholly-owned subsidiary of BioDelivery Sciences International, Inc., with an office at 801 Corporate Center Drive, Raleigh, North Carolina 27607 USA, and TTY Biopharm Co., Ltd., a corporation organized under the laws of the Republic of China , Taiwan with an office at 4F., No.174, Sec. 3, Min-Chuan E. Rd., Taipei, Taiwan, R.O.C (“TTY”). BDSI and TTY are sometimes referred to collectively herein as the “Parties” or singly as a “Party.”
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 8th, 2010 • Biodelivery Sciences International Inc • Pharmaceutical preparations • California
Contract Type FiledOctober 8th, 2010 Company Industry JurisdictionThis License and Supply Agreement (the “Agreement”) is made as of October 4, 2010 (the “Effective Date”) by and between Arius Pharmaceuticals, Inc. (“BDSI”), a Delaware corporation and wholly-owned subsidiary of BioDelivery Sciences International, Inc., with an office at 801 Corporate Center Drive, Raleigh, North Carolina 27607 USA, and TTY Biopharm Co., Ltd., a corporation organized under the laws of the Republic of China , Taiwan with an office at 4F., No.174, Sec. 3, Min-Chuan E. Rd., Taipei, Taiwan, R.O.C (“TTY”). BDSI and TTY are sometimes referred to collectively herein as the “Parties” or singly as a “Party.”